Adelbach Macari
Chief Financial Officer
Replay available
Corcept Therapeutics Incorporated (NASDAQ: CORT) Q2 2025 earnings conference call, held 2025-07-31. Replay captured from the company's public earnings webcast.

Chief Financial Officer
President, Endocrinology Division
Chief Business Officer
Chief Executive Officer
Analyst, Piper Sandler
Analyst, Truist Securities
Analyst, HCW Securities
Chief Development Officer
Watch the replay and follow the connected company analysis, news, and investor updates for Corcept Therapeutics Incorporated.
WEBVTT 00:00:00.031 -- 00:00:05.777 Thank you for standing by, and welcome to CoreSep Therapeutics' second quarter 2025 earnings 00:00:05.777 -- 00:00:11.103 conference call. At this time, all participants are in a listen-only mode. 00:00:11.103 -- 00:00:14.967 After the speaker presentation, there will be a question and answer session. 00:00:14.967 -- 00:00:19.712 To ask a question during the session, you will need to press star 1-1 on your telephone. 00:00:19.712 -- 00:00:23.877 To remove yourself from the queue, you may press star 1-1 again. 00:00:23.877 -- 00:00:27.821 I would now like to hand the call over to Adhavok Macari, CFO. 00:00:27.821 -- 00:00:30.462 Please go ahead. 00:00:30.642 -- 00:00:34.407 Thank you. Hello, everyone. Good afternoon, and thank you for joining us. 00:00:34.407 -- 00:00:38.292 Today, we issued a press release announcing our financial results for the second quarter 00:00:38.292 -- 00:00:42.397 and providing a corporate update. The copy is available at coursef.com. 00:00:42.397 -- 00:00:46.422 Our complete financial results will be available when we file our Form 10-Q with the 00:00:46.422 -- 00:00:51.528 SEC. Today's call is being recorded. A replay will be available of the investors' past 00:00:51.528 -- 00:00:55.674 events to have on our website. Statements during this call, other than statements of 00:00:55.674 -- 00:00:59.689 historical fact, are forward-looking statements based on our plans and expectations that 00:00:59.689 -- 00:01:03.635 are subject to risks and uncertainties, which might cause actual results to be materially 00:01:03.635 -- 00:01:06.959 different from those such statements express or imply. 00:01:06.959 -- 00:01:10.464 The risks and uncertainties that may affect our forward-looking statements are described 00:...